Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionNatixis Advisors, L.p.
Latest Disclosed Ownership2,236,156 shares
Latest Disclosed Value $ 341,573
Natixis Advisors, L.p. reports 166.72% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Natixis Advisors, L.p. filed a 13F-HR form disclosing ownership of 2,236,156 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $341,572,829 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 838,382 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 166.72% during the quarter. The current value of the position is $321,246,171 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVARTIS SPON ADR 66987V109 2,236,156 1,397,774 166.72 342 196.52 0.4751
2026-02-10 2025-12-31 13F NOVARTIS SPON ADR 66987V109 838,382 -61,636 -6.85 116 0.00 0.1638
2025-11-13 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 900,018 39,020 4.53 115 10.58 0.1684
2025-08-13 2025-06-30 13F NOVARTIS SPON ADR 66987V109 860,998 -10,972 -1.26 104 7.22 0.1653
2025-05-08 2025-03-31 13F NOVARTIS SPON ADR 66987V109 871,970 -495 -0.06 97 15.48 0.1796
2025-02-10 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 872,465 -66,379 -7.07 85 -21.50 0.1586
2024-11-06 2024-09-30 13F NOVARTIS SPN ADR 66987V109 938,844 26,317 2.88 108 10.31 0.2106
2024-08-01 2024-06-30 13F NOVARTIS SPON ADR 66987V109 912,527 -14,128 -1.52 97 8.99 0.2112
2024-04-25 2024-03-31 13F NOVARTIS SPON ADR 66987V109 926,655 -4,472 -0.48 90 -5.32 0.2061
2024-02-06 2023-12-31 13F NOVARTIS SPON ADR 66987V109 931,127 3,270 0.35 94 0.00 0.2475
2023-11-13 2023-09-30 13F NOVARTIS SPON ADR 66987V109 927,857 -2,553 -0.27 95 1.08 0.2890
2023-08-15 2023-06-30 13F NOVARTIS SPON ADR 66987V109 930,410 32,258 3.59 94 13.41 0.2899
2023-05-11 2023-03-31 13F NOVARTIS SPON ADR 66987V109 898,152 -353,451 -28.24 83 -27.43 0.2844
2023-01-27 2022-12-31 13F NOVARTIS SPON ADR 66987V109 1,251,603 -130,143 -9.42 114 -99.89 0.4292
2022-11-14 2022-09-30 13F NOVARTIS ADR 66987V109 1,381,746 -41,834 -2.94 105,027 -12.72 0.4443
2022-08-12 2022-06-30 13F NOVARTIS SPON ADR 66987V109 1,423,580 -317,146 -18.22 120,335 -21.22 0.5292
2022-05-12 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,740,726 50,023 2.96 152,748 3.29 0.5825
2022-02-08 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,690,703 -414,039 -19.67 147,885 -14.08 0.5647
2021-11-15 2021-09-30 13F NOVARTIS COM 66987V109 2,104,742 733,859 53.53 172,125 37.61 0.7079
2021-08-12 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,370,883 -32,675 -2.33 125,079 4.25 0.5838
2021-05-05 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,403,558 101,620 7.81 119,975 -2.41 0.6262
2021-02-12 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,301,938 215,686 19.86 122,943 30.15 0.7082
2020-11-12 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,086,252 -76,502 -6.58 94,461 -6.98 0.5944
2020-08-11 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,162,754 -51,554 -4.25 101,554 1.43 0.6740
2020-04-27 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,214,308 104,856 9.45 100,119 -4.70 0.8159
2020-02-10 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,109,452 82,276 8.01 105,054 17.69 0.7410
2019-11-12 2019-09-30 13F NOVARTIS SPON ADR 66987V109 1,027,176 -38,867 -3.65 89,261 -8.30 0.7085
2019-08-12 2019-06-30 13F NOVARTIS SPON ADR 66987V109 1,066,043 26,633 2.56 97,340 8.71 0.7950
2019-05-15 2019-03-31 13F/A-1 NOVARTIS COM 66987V109 1,039,410 29,127 2.88 89,545 3.29 0.7840
2019-05-15 2019-03-31 13F NOVARTIS COM 66987V109 1,039,410 29,127 89,545
2019-02-13 2018-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,010,283 120,270 13.51 86,692 13.05 0.8559
2019-02-13 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,010,283 120,270 86,692
2018-11-13 2018-09-30 13F NOVARTIS A G COM 66987V109 890,013 71,091 8.68 76,683 23.96 0.6750
2018-08-14 2018-06-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 818,922 -40,150 -4.67 61,860 -10.94 0.5909
2018-08-14 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 818,922 61,860
2018-05-10 2018-03-31 13F NOVARTIS A G COM 66987V109 859,072 16,571 1.97 69,456 -1.81 0.6855
2018-02-14 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 842,501 -51,531 -5.76 70,735 -7.84 0.7204
2017-11-14 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 894,032 -132,764 -12.93 76,751 -10.45 0.8108
2017-07-27 2017-06-30 13F NOVARTIS A G COM 66987V109 1,026,796 -20,802 -1.99 85,706 10.15 0.9277
2017-05-12 2017-03-31 13F NOVARTIS A G COM 66987V109 1,047,598 97,047 10.21 77,805 12.37 0.8621
2017-02-07 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 950,551 -59,193 -5.86 69,238 -13.16 0.8325
2016-11-04 2016-09-30 13F NOVARTIS A G COM 66987V109 1,009,744 46,601 4.84 79,730 0.33 1.0328
2016-08-01 2016-06-30 13F NOVARTIS A G COM 66987V109 963,143 186,584 24.03 79,468 41.26 1.0986
2016-05-06 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 776,559 200,917 34.90 56,255 13.58 0.8418
2016-02-12 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 575,642 16,267 2.91 49,527 -3.68 0.8119
2015-11-12 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 559,375 36,596 7.00 51,417 0.01 0.8918
2015-08-14 2015-06-30 13F NOVARTIS A G SPON ADR NEW 66987V109 522,779 41,757 8.68 51,410 8.38 0.8729
2015-05-15 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 481,022 47,281 10.90 47,434 18.02 0.8326
2015-02-05 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 433,741 67,984 18.59 40,190 16.73 0.7522
2014-11-03 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 365,757 -114,259 -23.80 34,429 -20.77 0.6908
2014-08-13 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 480,016 16,003 3.45 43,457 10.16 0.6227
2014-05-13 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 464,013 -29,607 -6.00 39,450 -0.57 0.6072
2014-02-12 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 493,620 -30,377 -5.80 39,678 -1.29 0.6494
2013-10-30 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 523,997 42,652 8.86 40,196 18.10 0.7402
2013-07-19 2013-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 481,345 481,345 34,036 0.6781
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.